{"id":"W4255248028","doi":"10.2165/00128413-200515060-00058","title":"Cetuximab [Erbitux; Bristol-Myers Squibb, ImClone Systems] injection has been approved by Health Canada's Biologics and Genetic Therapeutics Directorate","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bristol-Myers; Cetuximab; Family medicine; Pharmacy; Pharmacology; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004335925,0.0003635759,0.001176057,0.0002219335,0.0004973167,0.0002423455,0.0003085623,0.0001990605,0.0000584212],"category_scores_gemma":[0.0002401382,0.0004474508,0.00007452258,0.0002609031,0.0001394849,0.0003316333,0.00006528247,0.0003221336,0.000194844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002027163,"about_ca_system_score_gemma":0.0008571006,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3747374,"about_ca_topic_score_gemma":0.09191255,"domain_scores_codex":[0.9945278,0.0005490814,0.003252763,0.0007901181,0.0001502104,0.0007300121],"domain_scores_gemma":[0.9964825,0.0003761564,0.002201631,0.0004655775,0.00009469996,0.0003794708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000122864,0.0005325598,0.08712216,0.00147537,0.0006220493,0.000008625257,0.003286985,0.003831193,0.0004650271,0.002659844,0.8872188,0.01265448],"study_design_scores_gemma":[0.002081468,0.0002859916,0.01808863,0.00006888704,0.00002237504,0.00005410943,0.0009030132,0.03216196,0.00005522016,0.0002610369,0.9451971,0.0008201934],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7579746,0.06056487,0.004321105,0.1695308,0.002210804,0.002094382,0.002101061,0.0002340833,0.0009682692],"genre_scores_gemma":[0.9745799,0.001302935,0.001120333,0.02131985,0.000635733,0.0001252453,0.0001315229,0.00006901373,0.0007154814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2828248,"threshold_uncertainty_score":0.9997977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2486589550439336,"score_gpt":0.375657940229696,"score_spread":0.1269989851857624,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}